CCP Technologies Ltd (AGX)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:CCP Technologies Ltd (AGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013165
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CCP Technologies Ltd (CCP), formerly Agenix Ltd is a biotechnology company that offers molecule drugs. The company develops small molecule drugs and monoclonal antibody-based diagnostics for the treatment of various diseases. It develops DiagnostIQ rapid point-of-care human diagnostic technology and Thromboview patented technetium-99m-labelled antibody based radio-imaging test for venous thromboembolism (VTE). Agenix’s thromboembolism are used in test for conditions which include pulmonary embolism (PE), upper extremity venous thromboembolism (UEVTE) and deep vein thrombosis (DVT), among others. The company develops hand-held cassette technology that used in non-instrumented qualitative testing devices. CCP is headquartered in Broadbeach, Queensland, Australia.

CCP Technologies Ltd (AGX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CCP Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
CCP Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 9
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Agenix To Divest AGX-1009 To Chinese Pharma Company 11
Equity Offering 12
Agenix Completes Private Placement Of Shares For US$0.78 Million 12
Agenix Completes Rights Offering Of Shares For US$1.3 Million 13
Agenix Completes First Tranche Of Private Placement Of Shares For US$0.06 Million 14
Agenix Completes Private Placement Of Shares For US$0.1 Million 15
Agenix Completes Private Placement Of Shares For US$0.1 Million 16
Debt Offering 17
Agenix Announces Private Placement Of Notes Due 2013 For US$0.2 Million 17
CCP Technologies Ltd – Key Competitors 18
CCP Technologies Ltd – Key Employees 19
CCP Technologies Ltd – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Aug 30, 2016: AGENIX Announces Annual Result For The Year Ended 30 June 2016 21
Corporate Communications 22
Nov 21, 2016: Agenix: Retirement of Director 22
Oct 14, 2016: Agenix: Appointment of Independent Non- Executive Directors 23
Other Significant Developments 24
Nov 21, 2016: Agenix: Change of Registered Office 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CCP Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CCP Technologies Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
CCP Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 9
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Agenix To Divest AGX-1009 To Chinese Pharma Company 11
Agenix Completes Private Placement Of Shares For US$0.78 Million 12
Agenix Completes Rights Offering Of Shares For US$1.3 Million 13
Agenix Completes First Tranche Of Private Placement Of Shares For US$0.06 Million 14
Agenix Completes Private Placement Of Shares For US$0.1 Million 15
Agenix Completes Private Placement Of Shares For US$0.1 Million 16
Agenix Announces Private Placement Of Notes Due 2013 For US$0.2 Million 17
CCP Technologies Ltd, Key Competitors 18
CCP Technologies Ltd, Key Employees 19

★海外企業調査レポート[CCP Technologies Ltd (AGX)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Reno de Medici S.p.A.:企業の戦略・SWOT・財務情報
    Reno de Medici S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Reno de Medici S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Electricity Generating Public Co Ltd (EGCO):電力:M&Aディール及び事業提携情報
    Summary Electricity Generating Public Co Ltd (EGCO), a subsidiary of Electricity Generating Authority of Thailand (EGAT), is an energy utility. It produces electricity from natural gas, coal, biomass, waste, hydro, solar, wind, and geothermal sources. Through interests in independent power producer …
  • Severn Trent Plc (SVT):企業の財務・戦略的SWOT分析
    Severn Trent Plc (SVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Magnit:企業の戦略・SWOT・財務情報
    Magnit - Strategy, SWOT and Corporate Finance Report Summary Magnit - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Peako Ltd (PKO):企業の財務・戦略的SWOT分析
    Summary Peako Ltd (Peako), formerly Peak Oil & Gas Ltd, is a mineral exploration company. The company carries out the business of acquisition, exploration, and development of gold, silver and copper metals. Its projects include East Kimberley Region and Paterson Province. Peako’s East Kimberley Regi …
  • Hasbro Inc (HAS):企業の財務・戦略的SWOT分析
    Hasbro Inc (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bashas’ Inc.:企業の戦略・SWOT・財務情報
    Bashas' Inc. - Strategy, SWOT and Corporate Finance Report Summary Bashas' Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ABPA Holdings Ltd:企業の戦略的SWOT分析
    ABPA Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Handok Inc (002390)-製薬・医療分野:企業M&A・提携分析
    Summary Handok Inc (Handok), formerly known as Handok Pharmaceuticals Co Ltd, is a pharmaceutical and health care company which develops, manufactures and distributes healthcare solutions. The company develops and provides pharmaceutical products including prescription drugs, OTC drugs, medical devi …
  • Air Liquide Welding France, S.A.:企業の戦略・SWOT・財務情報
    Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report Summary Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Camaieu:企業の戦略・SWOT・財務情報
    Camaieu - Strategy, SWOT and Corporate Finance Report Summary Camaieu - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Aegerion Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aegerion Pharmaceuticals Inc (Aegerion) is a pharmaceutical company that develops therapies for patients with debilitating often fatal and rare diseases. The company provides therapeutics to treat severe inherited lipid disorders. Its therapeutic focus comprise homozygous familial hyperchole …
  • TUI AG (TUI1):企業の財務・戦略的SWOT分析
    TUI AG (TUI1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Big 5 Sporting Goods Corporation:企業の戦略・SWOT・財務情報
    Big 5 Sporting Goods Corporation - Strategy, SWOT and Corporate Finance Report Summary Big 5 Sporting Goods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Tianjin Zhonghuan Semiconductor Co Ltd (002129):企業の財務・戦略的SWOT分析
    Tianjin Zhonghuan Semiconductor Co Ltd (002129) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Cepheid:企業の戦略的SWOT分析
    Cepheid - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • XBiotech Inc (XBIT):製薬・医療:M&Aディール及び事業提携情報
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …
  • Sacgasco Ltd (SGC):企業の財務・戦略的SWOT分析
    Summary Sacgasco Ltd (Sacgasco) formerly Australian Oil Company Ltd, is an energy company that provides conventional oil and gas exploration, development and production across Australia. The company develops and produces clean natural gas in the Sacramento Basin, onshore California. It explores Sacr …
  • Costco Wholesale UK Limited:企業の戦略・SWOT・財務分析
    Costco Wholesale UK Limited - Strategy, SWOT and Corporate Finance Report Summary Costco Wholesale UK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Hoerbiger Holding AG:企業の戦略的SWOT分析
    Hoerbiger Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆